Background -Abnormalities of pulmonary function have been found in children with systemic lupus erythematosus (SLE) even in the absence of clinical or radiographic evidence of pulmonary involvement. It is unknown whether these abnormalities represent an early sign of progressive lung disease or whether they are associated with disease activity. Methods -After a mean of 4 5 years, respiratory function (forced vital capacity (FVC) and single breath gas transfer factor (TLCO)) and disease activity were reexamined in 13 of 15 previously studied children with SLE. Disease activity was assessed by a validated index of SLE activity (SLE activity measure (SLAM)). Results -In spite of the high prevalence of abnormalities of respiratory function at the baseline investigation, no chest radiographic abnormalities or overt clinical signs of lung disease were found at baseline, in the interval between the two investigations, or at the re-evaluation in any patient. From baseline to the second investigation the mean value of SLAM decreased and there was a trend toward an improvement in FVC and TLCO. TLCO was more severely impaired than FVC, being found as an isolated abnormality in a high percentage ofpatients (45% at baseline and 35% at follow up). There was a relationship between baseline TLCO and disease activity, expressed as a SLAM score. Moreover, there was a correlation between the changes in the SLAM score from baseline to the second investigation and the corresponding changes in the TLCO value, but not with the corresponding changes in the FVC value. Conclusions -In this series of patients the decrease in SLE activity from the first to the second investigation was associated with an improvement in pulmonary function. The presence of early isolated functional abnormalities was not associated with subsequent development of lung disease. (Thorax 1996;51:424-428) 
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We have previously found, in a cross sectional study, a high prevalence of functional abnormalities of the lung in children with clinically active connective tissue diseases, but not in those in remission.9 None of these patients had clinical or radiographic evidence of pulmonary involvement.
With the aim of investigating the long term evolution of pulmonary function and its relationship with changes in disease activity as assessed by standard methods, a group of children with systemic lupus erythematosus (SLE) previously studied was re-evaluated at least three years after a first evaluation.
Methods

STUDY DESIGN
Of 15 children with SLE included in the baseline investigation,10 two were lost from the second investigation. The remaining 13 patients (12 girls; age range 12-21 years) were re-evaluated after a mean of 4-5 years. Assessments of the disease activity, pulmonary function tests, oxygen saturation, and chest radiographic appearances were performed at baseline and at re-evaluation.
In the interval between the two investigations all the children had routine clinical examinations in the paediatric department every 3-6 months or more frequently if indicated. Pulmonary function tests and/or chest radiographs were also requested whenever clinically indicated.
PATIENTS
The main demographic and clinical data of the 13 patients are summarised in table 1 . The duration of the disease at the time of the baseline investigation ranged from one to 57 months. None ofthe children had a past history of pleural or pulmonary involvement. All the children were receiving drug treatment, whose dosage and regimen were adapted at each visit according to the severity and activity of the disease. All patients received prednisone, six were taking azathioprine, four cyclo- urements were registered. The transfer factor of the lung for carbon monoxide (TLCO) was determined using the single breath method (Transferscreen-II Jaeger, Wuerzburg, Germany) and corrected for haemoglobin content. Since the correction of TLCO for alveolar volume did not influence the results of our analysis, only uncorrected TLCO values were reported. TLCO measurement was unreliable in two patients. Oxygen saturation was measured by means of a pulse oximeter (Oxy Shuttle, Sensor Medics, California, USA). All the respiratory function tests were performed according to the European Community for Coal and Steel statement.'3 Since in our previous work the most informative variables were found to be FVC and TLCO,9 only these parameters were included in the analysis. Changes in FVC and TLCO between the first and second investigation were considered significant when they exceeded the normal variability of the test itself (>15% for FVC; >10% for TLCO).13
A cross sectional study on lung function in healthy schoolchildren aged 4-6-18-8 years has recently been performed and reference standards throughout childhood and puberty are now available.'4 15 We employed these reference equations and, in accordance with the ECCS statement, '3 we expressed the data from our subjects as a standard deviation (SD) score (actual result -predicted results/population standard deviation) and defined it as pathological when the value was less than -1 64, corresponding to less than the fifth percentile. Taking into account the pubertal stage of each subject at each respiratory function assessment, the SD score was corrected according to the tables reported by Rosenthal et al. ' The comparison between the mean baseline and control values of respiratory functional data and the disease activity measure was performed by a paired t test. Simple linear regression analysis was employed to evaluate the correlation between baseline FVC, TLCO, and baseline SLAM, and between the changes in the FVC and TLCO along with changes in the SLAM from the first to the second investigation. Changes in the functional parameters were determined as the difference (A) between each control and baseline SD score and changes in disease activity as the difference (A) between each control and baseline SLAM score.
Results
No overt clinical signs of lung disease or chest radiographic abnormalities were found at baseline, in the interval between the two investigations, or at re-evaluation in any patient, including those with the most severe abnormalities in lung function tests. Table 2 reports the individual values of SLAM, FVC, and TLCO for each child at base- line and at the second assessment. Table 3 shows the mean (SD) baseline and repeat values for SLAM, FVC, and TLCO, and the percentage of subjects with a negative SD score and with a clearly pathological SD score (<-1 64). The mean SLAM score decreased significantly between baseline and re-evaluation (p<005). The mean values of FVC and TLCO were negative both at baseline and at repeat measurement. Although the difference was not statistically significant, there was a trend towards an improvement in both respiratory parameters from the first to the second investigation. The percentage of patients with a negative SD score and clearly pathological respiratory function was slightly reduced at reevaluation. TLCO was more severely impaired than FVC both at baseline and at the second examination, being found as an isolated abnormality in a high percentage ofpatients (45% at baseline and 35% at control). At baseline only TLCO was significantly correlated with SLAM (r=0-65, p<005) (fig 1) . From baseline to the second investigation the SLAM score improved in seven subjects, was unchanged in four, and worsened in two. The FVC value improved in seven subjects, was unchanged in four, and worsened in two ( fig  2) . The TLCO value improved in five subjects, remained unchanged in three, and worsened in three (fig 3) . The changes in the TLCO value from baseline to re-evaluation were significantly correlated with the corresponding changes in the SLAM scores (r=062, p<005) (fig 4) , while the changes in the FVC were not. Of note, the three patients who showed the more impressive improvement in TLCo at reevaluation (from severely abnormal to normal values) concurrently achieved a clinical remission.
Oxygen saturation was normal (>95%) in all the patients, even in the most compromised, both at baseline and at re-evaluation.
Discussion
Our study in 13 children with SLE shows that functional lung impairment is related to the activity of the systemic inflammatory process. This finding is in agreement with the results of our previous cross sectional investigation.9 Indeed, we found a relationship between TLCO impairment and the activity of the disease expressed as a SLAM score. Moreover, from the first to the second assessment we observed a significant correlation between lessening of disease activity and improvement of TLCO. As in adult onset SLE, TLCO was more severely impaired than FVC.'7 A low FVC may be due to either respiratory muscle function impairment or to interstitial lung disease,6 17 18 but the finding of a proportionately lower TLCO than FVC suggests that there is a pulmonary parenchymal defect rather than respiratory 
